You are here

  • Home
  • Online First
  • Idylla EGFR assay on extracted DNA: advantages, limits and place in molecular screening according to the latest guidelines for non-small-cell lung cancer (NSCLC) patients

Citation Tools

Article menu
Download PDFPDF
Original research
Idylla EGFR assay on extracted DNA: advantages, limits and place in molecular screening according to the latest guidelines for non-small-cell lung cancer (NSCLC) patients

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Khalifa E, Chapusot C, Tournier B, et al
Idylla EGFR assay on extracted DNA: advantages, limits and place in molecular screening according to the latest guidelines for non-small-cell lung cancer (NSCLC) patients
Journal of Clinical Pathology Published Online First: 12 July 2022. doi: 10.1136/jcp-2022-208325